Keywords
- Immunoglobulin G1, anti-(human tumor necrosis factor α) (human monoclonal CNTO 148 γ1-chain), disulfide with human monoclonal CNTO 148 κ-chain, dimer
- CNTO 148
Quick Details
- ProName: Golimumab
- CasNo: 476181-74-5
- Application: For research use only.
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Golimumab product for your project.
Details
Golimumab is a monoclonal antibody used in the treatment of autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Golimumab targets and inhibits tumor necrosis factor alpha (TNF-α), a cytokine involved in the inflammatory pathway that contributes to autoimmune diseases. By blocking TNF-α, golimumab helps to reduce inflammation and alleviate symptoms associated with these conditions.